Syndrome News and Research

RSS

Study offers new protocols for high-quality SARS-CoV-2 genomic sequencing

Researchers at the Southern Illinois University, U.S.A. have presented a comprehensive and well-validated set of working protocols for sequencing high-quality SARS-CoV-2 genomes in high throughput from patient samples.

12 Feb 2021

New article reviews how the circadian clock controls various aspects of homeostasis

Subconsciously, our bodies keep time for us through an ancient means - the circadian clock. A new University of California, Irvine-led article reviews how the clock controls various aspects of homeostasis, and how organs coordinate their function over the course of a day.

12 Feb 2021

Researchers receive $1,894,271 grant to address new drug targets for diastolic dysfunction

After the left ventricle of the heart contracts, it must relax efficiently to prepare to refill and supply the body with blood on the next beat. An increasing number of patients -- including nearly all patients with heart failure -- suffer from impaired relaxation, which is part of a clinical syndrome known as diastolic dysfunction. Currently, treatments for impaired relaxation do not exist.

12 Feb 2021

Statins shown to reduce COVID-19 severity and lower mortality

Much attention has been focused on ways to reduce the deadly exaggeration of normal inflammatory reactions to this pathogen. A new research paper posted to the medRxiv* preprint server describes the alleviation of hyper-inflammatory phenomena following the administration of statins, drugs more widely known for their use in reducing blood cholesterol levels, to patients with COVID-19.

11 Feb 2021

The impact of SARS-CoV-2 on pregnancy in Nordic countries

Population-based studies are essential to gain knowledge of the spread and management of this disease. However, most studies on pregnancy during COVID-19 have not been broadly applicable to Nordic populations, like most current COVID-19 research in general.

11 Feb 2021

New SARS-CoV-2 variant found in newborn child with seizures in the United States

Researchers at a hospital in Washington D.C. found a new mutant strain of the virus in a neonatal patient with high viral loads. According to the authors, this strain could be spreading in the United States mid-Atlantic population and needs monitoring.

11 Feb 2021

Self-assessment of face coverings lowers protection against SARS-CoV-2

Researchers in the United States have conducted a study demonstrating that personal assessment of whether respirators and face masks fit properly cannot be relied on in efforts to protect against infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

11 Feb 2021

SARS-CoV-2 evolves antibody resistance in immunocompromised patient

Researchers in the United States who tracked the evolution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in an immunocompromised patient found that convalescent plasma therapy was associated with the emergence of viral variants that were less susceptible to neutralizing antibodies.

11 Feb 2021

Brain pericytes serve as a potential hub for SARS-CoV-2 infection

A team of scientists from the United States has recently conducted a study using pericyte-like cell-containing brain cortical organoids as an experimental model to investigate the impact of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection on the central nervous system.

11 Feb 2021

Adults with intellectual disabilities are particularly vulnerable to COVID-19, study finds

Researchers at the University of Glasgow and the Manchester Metropolitan University in the U.K. report that adults with intellectual disabilities have a higher risk of being infected with SARS-CoV2. They are also more likely to develop worse outcomes once infected.

11 Feb 2021

Study offers a new way to treat children with bow hunter syndrome

Fusing the neck's top two vertebrae can prevent repeat strokes in children with bow hunter syndrome, a rare condition that affects a handful of U.S. pediatric patients each year, UT Southwestern researchers suggest in a recent study.

11 Feb 2021

Higher proportion of male children develop COVID-19-related Multisystem Inflammatory Syndrome, finds study

Previous studies about COVID-19 have shown that the illness is often more severe in men than women. However, there is limited data available for the pediatric population. Though children and adolescents are at a lower risk of developing severe illness, some may experience severe symptoms. In some cases, children develop complications, including the multisystem inflammatory syndrome in children (MIS-C). Researchers report that a higher percentage of male children developed MIS-C and died.

11 Feb 2021

New study shares preliminary data on Pfizer vaccine’s effectiveness in Israel

Researchers have shown that by mid-January, the number of COVID-19 cases and hospitalizations in Israel began to decline with a larger and earlier decrease among older people.

11 Feb 2021

Breastfeeding women produce COVID-19 antibodies that neutralize the virus

Breastfeeding women with COVID-19 do not pass along the SARS-CoV-2 virus in their milk but do transfer milk-borne antibodies that are able to neutralize the virus, a multi-institutional team of researchers led by the University of Idaho reported.

11 Feb 2021

New research examines how alcohol exposure impacts aspects of neuroplasticity

New research and analysis examine how alcohol exposure impacts many aspects of neuroplasticity in a special issue of Brain Plasticity

11 Feb 2021

Playing sport during COVID-19 pandemic eased anxiety and depression for students

School sports came to an abrupt halt during the COVID-19 (coronavirus disease 2019) pandemic. How this impacted adolescents' health, who were otherwise generally active in sports in their school, is examined in new research. What happened when adolescent athletes returned to organized sport in this pandemic?

10 Feb 2021

Second dose of Pfizer-BioNTech COVID-19 vaccine may not benefit previously infected individuals

Researchers at the NYU Grossman School of Medicine have shown that a second dose of the Pfizer-BioNTech BNT162b2 vaccine may not offer any additional protection against coronavirus disease 2019 (COVID-19) over one dose among individuals previously infected with the causative agent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

10 Feb 2021

Syndrome News and Research

Study offers new protocols for high-quality SARS-CoV-2 genomic sequencing

New article reviews how the circadian clock controls various aspects of homeostasis

Researchers receive $1,894,271 grant to address new drug targets for diastolic dysfunction

Statins shown to reduce COVID-19 severity and lower mortality

The impact of SARS-CoV-2 on pregnancy in Nordic countries

New SARS-CoV-2 variant found in newborn child with seizures in the United States

Self-assessment of face coverings lowers protection against SARS-CoV-2

SARS-CoV-2 evolves antibody resistance in immunocompromised patient

Brain pericytes serve as a potential hub for SARS-CoV-2 infection

Adults with intellectual disabilities are particularly vulnerable to COVID-19, study finds

Study offers a new way to treat children with bow hunter syndrome

Higher proportion of male children develop COVID-19-related Multisystem Inflammatory Syndrome, finds study

New study shares preliminary data on Pfizer vaccine’s effectiveness in Israel

Breastfeeding women produce COVID-19 antibodies that neutralize the virus

New research examines how alcohol exposure impacts aspects of neuroplasticity

Playing sport during COVID-19 pandemic eased anxiety and depression for students

Second dose of Pfizer-BioNTech COVID-19 vaccine may not benefit previously infected individuals

Substrain of SARS-CoV-2 variant in UK may resist antibody neutralization

Could Galectin-3 be a potential biomarker to help identify severe COVID-19 early?

Study shows local topological free energy as determinant of SARS-CoV-2 spike stability

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News